GSK plc (LON:GSK)

Market Cap	59.11B
Revenue (ttm)	31.63B
Net Income (ttm)	3.42B
Shares Out	4.03B
EPS (ttm)	0.83
PE Ratio	17.76
Forward PE	8.56
Dividend	0.61 (4.16%)
Ex-Dividend Date	Aug 14, 2025

Volume	981,075
Average Volume	6,917,989
Open	1,456.50
Previous Close	1,467.50
Day's Range	1,450.00 - 1,468.00
52-Week Range	1,242.50 - 1,678.68
Beta	0.29
RSI	56.30
Earnings Date	Oct 29, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1715
• Employees: 68,629
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.